Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000904454-04-000094
Filing Date
2004-02-12
Accepted
2004-02-12 15:32:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G, AMENDMENT NO. 1 s13ga_021104.txt SC 13G/A 9166
  Complete submission text file 0000904454-04-000094.txt   11113
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 7325242454
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44055 | Film No.: 04591294
SIC: 2836 Biological Products, (No Diagnostic Substances)